WPG Advisers’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69K Hold
34
﹤0.01% 1123
2026
Q1
$2.93K Sell
34
-11
-24% -$987 ﹤0.01% 1006
2025
Q4
$3.93K Hold
45
﹤0.01% 959
2025
Q3
$2.58K Buy
45
+1
+2% +$58 ﹤0.01% 1075
2025
Q2
$2.6K Sell
44
-3
-6% -$194 ﹤0.01% 1061
2025
Q1
$3.44K Buy
47
+11
+31% +$909 ﹤0.01% 986
2024
Q4
$2.98K Buy
+36
New +$2.84K ﹤0.01% 977

Other funds holding GMED

WPG Advisers's GMED Position: Q2 2026 in Review

WPG Advisers held its Globus Medical (GMED) position steady in Q2 2026 at 34 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

WPG Advisers first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.93K in Q4 2025. 293 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • WPG Advisers held 34 shares of Globus Medical worth $2.69K as of Q2 2026.
  • WPG Advisers left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1123 holding.
  • WPG Advisers first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Globus Medical position peaked at $3.93K in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.